Medical Condition News

RSS

‘Still Alice’ movie portrays young onset dementia

"An Academy Award for this movie would be a triumph," says Brian Appleby, MD, geriatric psychiatrist at University Hospitals Case Medical Center about the movie, "Still Alice," starring Julianne Moore.

25 Feb 2015

Isis Pharmaceuticals announces positive results from Phase 1 study of ISIS-PKK Rx for HAE treatment

Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-PKKRx. In this study, healthy volunteers treated with ISIS-PKKRx achieved dose-dependent reductions of up to 95 percent in prekallikrein, or PKK. ISIS-PKKRx is a RNA-targeted antisense drug designed to inhibit the production of PKK for the prophylactic treatment of hereditary angioedema (HAE).

24 Feb 2015

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

According to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Acute Lymphoblastic Leukemia (ALL), the treatment approach to ALL is one of the most complex and intensive programs in cancer therapy.

24 Feb 2015

Diets high in animal proteins can worsen progression of kidney disease

An estimated 26 million people in the United States have chronic kidney disease, which can lead to complete kidney failure. Once the kidneys fail, patients either need to undergo dialysis treatments three times a week or have a kidney transplant to remain alive.

24 Feb 2015

People who exhibit resistance to aspirin may be at risk of more severe strokes

People who exhibit a resistance to aspirin may be more likely to have more severe strokes than people who still respond to the drug, according to a study released today that will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.

24 Feb 2015

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania's Abramson Cancer Center during the 2015 Genitourinary Cancers Symposium.

24 Feb 2015

New study could lead to better remedies for insomnia, more effective anaesthetic drugs

Scientists have discovered that switching on one area of the brain chemically can trigger a deep sleep.

24 Feb 2015

NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

Michael M. Halassa, MD, PhD, assistant professor, Departments of Psychiatry and Neuroscience and Physiology at NYU Langone Medical Center's Neuroscience Institute, has been selected as a winner of the 2015 Sloan Research Fellowship.

24 Feb 2015

Researchers find key protein critical to the success of common anti-platelet drug Plavix

Researchers at the UNC School of Medicine have found that the blood platelet protein Rasa3 is critical to the success of the common anti-platelet drug Plavix, which breaks up blood clots during heart attacks and other arterial diseases.

24 Feb 2015

RD Biomed to launch reflux diagnostic study in China

RD Biomed, the Hull-based medical technology company, will launch a study with over 1,000 patients in China to measure the effectiveness of its reflux diagnostic device Peptest.

24 Feb 2015

Boehringer Ingelheim presents Phase III data for tiotropium at 2015 AAAAI Annual Meeting

Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat inhaler from five Phase III trials from the UniTinA-asthma program at the 2015 American Academy of Allergy, Asthma & Immunology Annual Meeting in Houston, Texas.

24 Feb 2015

MD Anderson researchers find way to predict patients who may respond to BRAF inhibitors

Powerful drugs known as BRAF-inhibitors have been crucial for melanoma patients, saving lives through their ability to turn off the BRAF protein's power to spur cancer cell growth.

24 Feb 2015

Study results report no benefit from use of sunitinib, sorafenib among patients with kidney cancer

Research results highlighted today at the press conference of a major medical meeting report no benefit from the use of either Sutent (sunitinib) or Nexavar (sorafenib) among patients with locally advanced renal cell carcinoma at high risk of recurrence, the ECOG-ACRIN Cancer Research Group announced.

24 Feb 2015

Rogers Behavioral Health announces addition of eating disorder program to Tampa location

Rogers Behavioral Health-Tampa Bay announced today that it is adding a partial hospitalization eating disorder program to its Tampa location beginning March 30. This news is particularly timely as the nation recognizes National Eating Disorder Awareness Week February 22-28.

23 Feb 2015

Fox Chase Cancer Center's Radiation Oncology Department earns ACR accreditation

Fox Chase Cancer Center's Radiation Oncology Department, an international leader known for offering the latest advancements in radiation treatment, has earned accreditation from the American College of Radiology for another three years at both its main campus in Northeast Philadelphia and Buckingham facility.

23 Feb 2015

Finding opens avenues of research toward precision treatments to boost life expectancy for CF patients

Mutation of one gene is all it takes to get cystic fibrosis (CF), but disease severity depends on many other genes and proteins. For the first time, researchers at the UNC School of Medicine have identified genetic pathways - or clusters of genes - that play major roles in why one person with CF might never experience the worse kinds of symptoms while another person will battle severe airway infection for a lifetime.

23 Feb 2015

Christopher & Dana Reeve Foundation announces Quality of Life grants for 75 nonprofit organizations

The Christopher & Dana Reeve Foundation, a leading nonprofit dedicated to improving quality of life for individuals living with paralysis, announced it has awarded $600,137 in Quality of Life grants to 75 nonprofit organizations nationwide.

23 Feb 2015

Rigel, Bristol-Myers Squibb partner to develop, commercialize TGF beta receptor kinase inhibitors

Rigel Pharmaceuticals, Inc. and Bristol-Myers Squibb Company today announced that they have entered into a collaboration agreement for the discovery, development and commercialization of cancer immunotherapies based on Rigel's extensive portfolio of small molecule TGF beta receptor kinase inhibitors.

23 Feb 2015

IRIDEX to unveil Cyclo G6 laser system for treatment of glaucoma at AGS annual congress

IRIDEX Corporation today announced that it will debut Cyclo G6, the Company's first laser platform dedicated to the treatment of glaucoma, at this year's annual congress of the American Glaucoma Society.

23 Feb 2015

Taiho Oncology announces acceptance of TAS-102 NDA for review by FDA

Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced the New Drug Application (NDA) for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), has been accepted for review by the U.S. Food and Drug Administration.

23 Feb 2015

Medical Condition News

‘Still Alice’ movie portrays young onset dementia

Isis Pharmaceuticals announces positive results from Phase 1 study of ISIS-PKK Rx for HAE treatment

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

Diets high in animal proteins can worsen progression of kidney disease

People who exhibit resistance to aspirin may be at risk of more severe strokes

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

New study could lead to better remedies for insomnia, more effective anaesthetic drugs

NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

Researchers find key protein critical to the success of common anti-platelet drug Plavix

RD Biomed to launch reflux diagnostic study in China

Boehringer Ingelheim presents Phase III data for tiotropium at 2015 AAAAI Annual Meeting

MD Anderson researchers find way to predict patients who may respond to BRAF inhibitors

Study results report no benefit from use of sunitinib, sorafenib among patients with kidney cancer

Rogers Behavioral Health announces addition of eating disorder program to Tampa location

Fox Chase Cancer Center's Radiation Oncology Department earns ACR accreditation

Finding opens avenues of research toward precision treatments to boost life expectancy for CF patients

Christopher & Dana Reeve Foundation announces Quality of Life grants for 75 nonprofit organizations

Rigel, Bristol-Myers Squibb partner to develop, commercialize TGF beta receptor kinase inhibitors

IRIDEX to unveil Cyclo G6 laser system for treatment of glaucoma at AGS annual congress

Taiho Oncology announces acceptance of TAS-102 NDA for review by FDA

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News